A reliable protocol for the isolation of viable, chondrogenically differentiated human mesenchymal stem cells from high-density pellet cultures

BioResearch Open Access

Volumn 1, Issue 6, 2012, Pages 297-305

  Ullah, Mujib ^a   Hamouda, Houda ^b   Stich, Stefan ^a   Sittinger, Michael ^a   Ringe, Jochen ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Clinical Chemistry   (Germany)

Author keywords

cell isolation; chondrogenic differentiation; enzymatic pellet digestion; extracellular matrix

Indexed keywords

ALCIAN BLUE; COLLAGEN TYPE 2; COLLAGENASE; PROTEOGLYCAN; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA3; TRYPSIN;

ADULT; AGED; ARTICLE; CARTILAGE CELL; CASE REPORT; CELL DIFFERENTIATION; CELL ISOLATION; CONTROLLED STUDY; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MARKER GENE; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84883566749     PISSN: None     EISSN: 21647860     Source Type: Journal    
DOI: 10.1089/biores.2012.0279     Document Type: Article

References (39)

1. Pearle AD, Warren RF, Rodeo SA. Basic science of articular cartilage and osteoarthritis. Clin Sports Med. 2005;24:1-12.
2. Tetteh ES, Bajaj S, Ghodadra NS. Basic science and surgical treatment options for articular cartilage injuries of the knee. J Orthop Sports Phys Ther. 2012;42:243-253.
3. Bhosale AM, Richardson JB. Articular cartilage: structure, injuries and review of management. Br Med Bull. 2008;87: 77-95.
4. Temenoff JS, Mikos AG. Review: tissue engineering for regeneration of articular cartilage. Biomaterials. 2000;21: 431-440.
5. Seed SM, Dunican KC, Lynch AM. Osteoarthritis: a review of treatment options. Geriatrics. 2009;64:20-29.
6. Swift A. Osteoarthritis 1: physiology, risk factors and causes of pain. Nurs Times. 2012;108:12-15.
7. Chiang H, Jiang CC. Repair of articular cartilage defects: review and perspectives. J Formos Med Assoc. 2009;108:87-101.
8. Brittberg M, Lindahl A, Nilsson A, et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med. 1994;331:889-895.
9. Meyer U, Wiesmann HP, Libera J, et al. Cartilage defect regeneration by ex vivo engineered autologous microtissue - preliminary results. In Vivo. 2012;26:251-257.
10. Ringe J, Burmester GR, Sittinger M. Regenerative medicine in rheumatic disease - progress in tissue engineering. Nat Rev Rheumatol. 2012;8:493-498.
11. Loeser RF. Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix. Osteoarthritis Cartilage. 2009;17:971-979.
12. Martin JA, Brown T, Heiner A, Buckwalter JA. Posttraumatic osteoarthritis: the role of accelerated chondrocyte senescence. Biorheology. 2004;41:479-491.
13. Tang QO, Carasco CF, Gamie Z, et al. Preclinical and clinical data for the use of mesenchymal stem cells in articular cartilage tissue engineering. Expert Opin Biol Ther. 2012;12: 1361-1382.
14. Barbero A, Ploegert S, Heberer M, Martin I. Plasticity of clonal populations of dedifferentiated adult human articular chondrocytes. Arthritis Rheum. 2003;48:1315-1325.
15. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143-147.
16. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315-317.
17. Jorgensen C, Noel D. Mesenchymal stem cells in osteoarticular diseases. Regen Med. 2011;6:44-51.
18. Benthien JP, Behrens P. The treatment of chondral and osteochondral defects of the knee with autologous matrix-induced chondrogenesis (AMIC): method description and recent developments. Knee Surg Sports Traumatol Arthrosc. 2011;19: 1316-1319.
19. Siclari A, Mascaro G, Gentili C, et al. A cell-free scaffoldbased cartilage repair provides improved function hyalinelike repair at one year. Clin Orthop Relat Res. 2012;470: 910-919.
20. Johnstone B, Hering TM, Caplan AI, et al. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res. 1998;238:265-272.
21. Eyre DR, Weis MA, Wu JJ. Articular cartilage collagen: an irreplaceable framework? Eur Cell Mater. 2006;12:57-63.
22. Qi WN, Scully SP. Type II collagen modulates the composition of extracellular matrix synthesized by articular chondrocytes. J Orthop Res. 2003;21:282-289.
23. Roughley PJ. The structure and function of cartilage proteoglycans. Eur Cell Mater. 2006;12:92-101.
24. Mrugala D, Dossat N, Ringe J, et al. Gene expression profile of multipotent mesenchymal stromal cells: identification of pathways common to TGFbeta3/BMP2-induced chondrogenesis. Cloning Stem Cells. 2009;11:61-76.
25. Ringe J, Sittinger M. Tissue engineering in the rheumatic diseases. Arthritis Res Ther. 2009;11:211.
26. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:e45.
27. Wu Q, Li C, Li C, et al. Purification and characterization of a novel collagenase from Bacillus pumilus Col-J. Appl Biochem Biotechnol. 2010;160:129-139.
28. Petrova D, Derekova A, Vlahov S. Purification and properties of individual collagenases from Streptomyces sp. strain 3B. Folia Microbiol (Praha). 2006;51:93-98.
29. Mohal JS, Tailor HD, Khan WS. Sources of adult mesenchymal stem cells and their applicability for musculoskeletal applications. Curr Stem Cell Res Ther. 2012;7:103-109.
30. Hayman DM, Blumberg TJ, Scott CC, Athanasiou KA. The effects of isolation on chondrocyte gene expression. Tissue Eng. 2006;12:2573-2581.
31. Wolf F, Candrian C, Wendt D, et al. Cartilage tissue engineering using pre-aggregated human articular chondrocytes. Eur Cell Mater. 2008;16:92-99.
32. Dehne T, Karlsson C, Ringe J, et al. Chondrogenic differentiation potential of osteoarthritic chondrocytes and their possible use in matrix-associated autologous chondrocyte transplantation. Arthritis Res Ther. 2009;11:R133.
33. Endres M, Neumann K, Schroder SE, et al. Human polymerbased cartilage grafts for the regeneration of articular cartilage defects. Tissue Cell. 2007;39:293-301.
34. Gigout A, Jolicoeur M, Buschmann MD. Low calcium levels in serum-free media maintain chondrocyte phenotype in monolayer culture and reduce chondrocyte aggregation in suspension culture. Osteoarthritis Cartilage. 2005;13: 1012-1024.
35. Lefebvre V, Smits P. Transcriptional control of chondrocyte fate and differentiation. Birth Defects Res C Embryo Today. 2005;75:200-212.
36. Gigout A, Jolicoeur M, Nelea M, et al. Chondrocyte aggregation in suspension culture is GFOGER-GPP- and beta1 integrin- dependent. J Biol Chem. 2008;283:31522-31530.
37. Henson FM, Getgood AM, Caborn DM, et al. Effect of a solution of hyaluronic acid-chondroitin sulfate-N-acetyl glucosamine on the repair response of cartilage to single-impact load damage. Am J Vet Res. 2012;73:306-312.
38. Marti-Bonmati L, Sanz-Requena R, Rodrigo JL, et al. Glucosamine sulfate effect on the degenerated patellar cartilage: preliminary findings by pharmacokinetic magnetic resonance modeling. Eur Radiol. 2009;19:1512-1518.
39. Taniguchi S, Ryu J, Seki M, et al. Long-term oral administration of glucosamine or chondroitin sulfate reduces destruction of cartilage and up-regulation of MMP-3 mRNA in a model of spontaneous osteoarthritis in Hartley guinea pigs. J Orthop Res. 2012;30:673-678.